HEAL Foundation Announces Healthcare CSR Summit & Awards in New Delhi
The HEAL Foundation is excited to announce its Healthcare CSR Summit & Awards, scheduled for September 5th, 2024, to be held at India Habitat Centre, New Delhi. This landmark event will bring together leaders from the healthcare and corporate social…
Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System
Soterix Medical Inc., the global leader in stimulation and synergistic monitoring technologies, announced today it has received a 510(k) clearance from the U.S. Food & Drug Administration for its Intraoperative Neurophysiologic Monitoring (IOM) system, MEGA-IOM. The system provides unmatched integrated control…
KT TAPE LAUNCHES PRO – SIGNATURE SARA HUGHES LIMITED EDITION TAPE AHEAD OF OLYMPIC AND PARALYMPIC GAMES 2024
KT®, the leading kinesiology tape brand and the official kinesiology tape licensee of the U.S. Olympic and Paralympic Teams, announces today the launch of its new KT Tape Pro® Signature Sara Hughes Limited Edition Pro Extreme Tape. This exclusive product…
Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires
In response to the critical need for safe storage and charging of lithium-ion batteries, Justrite announces the launch of its state-of-the-art Lithium-Ion Battery Charging Cabinet. Featuring the innovative 9-Layer ChargeGuard™ Containment System, this cutting-edge cabinet is engineered to prevent catastrophic losses…
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated in Harbin, Heilongjiang province, China, marking a significant advance in the province’s efforts to address public health challenges. Utilizing the ‘13311i GigaLab’ technological framework, this facility supports vital life…
High Potent Containment Provider ONFAB Enters USA Market
ONFAB, a leading European provider of single-use, flexible containment solutions for the pharmaceutical industry, has officially launched business operations in the United States in conjunction with parent company Savillex. The company’s American hub will be located within the Savillex headquarters in Eden Prairie,…
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects
The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of precancer, with over 40 million Americans a year developing this condition. Treating AKs before…
Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure
CSL Vifor today announced that Health Canada has authorized Ferinject (ferric carboxymaltose) for the intravenous (IV) treatment of iron deficiency anemia in adult and pediatric patients one year of age and older when oral iron preparations are not tolerated or are ineffective,…
Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Rezdiffra (resmetirom) in conjunction with diet and exercise for…
Arctic Therapeutics and Nacuity Pharmaceuticals Announce European Medicines Agency Approval to Initiate First Clinical Trial of AT-001 (NPI-001) for the Treatment of HCCAA
Arctic Therapeutics ehf, an Icelandic drug development company and partner Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, today announced approval by the European Medicines Agency (EMA) for…
